XHALE SMART® | An Xhale, Inc. Company
Smart® – Disease Management
SMART® has numerous potential applications in Disease Management. Early candidates for SMART® are conditions where behavioral challenges make patient adherence especially critical, including management of cognitive impairment (Alzheimer’s and related diseases), seizure disorders and certain psychiatric disorders.
Other diseases where SMART® can benefit patients include diabetes, CHF, COPD, stroke and neurological diseases, where measuring patient adherence can be a key tool in determining efficacy of therapeutic agents.
The SMART System has not been cleared by the FDA for marketing in the disease management market.
